Schedule 13G ownership disclosure
MATINAS BIOPHARMA HLDGS INC
Common Stock, par value $0.0001 per share · CUSIP: 576810303
Event date: 2025-08-15
- Filing-level shares
- 545,000.00
- Percent of class
- 9.81%
- Lazar David E.
Shares: 545,000.00 · Class: 9.81%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-002331
- Form type
- SCHEDULE 13G
- Filer
- Lazar David E.
- CIK
- CIK 1932843
- Filed
- Aug 19, 2025
- Reporting period
- Aug 15, 2025
- Description
- Schedule 13G beneficial ownership